In October 2012, the American and European Diabetes Societies published a new consensus on diabetes treatment goals, based on information from evidence-based medicine. Because older patients often have other medical conditions, and even more so end-stage chronic conditions, these patients should be treated separately rather than “one size fits all. 1. Basically healthy, with a few coexisting chronic diseases and good cognitive and other functions; requirements: glycemic control target is glycosylated hemoglobin <7.5%, blood pressure <140/80 mmHg, dyslipidemia with statins. 2.More complicated condition, moderate degree, multiple co-existing chronic diseases, two or more diseases affecting daily life, mild or moderate impairment of cognitive function; requirements: glycosylated hemoglobin <8.0%, blood pressure <140/80mmHg, and statins for dyslipidemia. 3. Very complicated condition, poor health, long-term or terminal chronic disease, moderate to severe cognitive impairment, unable to take care of themselves in daily life; requirements: glycosylated hemoglobin <8.5%, blood pressure <150/90mmHg, statins should be used only after considering the pros and cons. The consensus is that the elderly should be screened for diabetes and treated early. Physical activity and dietary control should be carried out under safe and appropriate conditions. Glyburide is not advocated as a medication, and metformin is preferred, but not used in severe kidney disease. Consider multiple hypoglycemic drugs and measure blood glucose more often to avoid hypoglycemia.